COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Abstract Background The SARS-CoV-2 pandemic was a challenge for health care systems worldwide. People with pre-existing chronic diseases have been identified as vulnerable patient groups. Furthermore, some of the drugs used for these chronic diseases such as antihypertensive drugs have been discusse...
Saved in:
Main Authors: | Roland Linder, Jonas Peltner, Anatoli Astvatsatourov, Willy Gomm, Britta Haenisch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-024-21110-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01) -
Probable Relationship between COVID-19, Pollutants and Meteorology: A Case Study at Santiago, Chile
by: Giovanni A. Salini, et al.
Published: (2021-01-01) -
COVID-19 Outbreak: Routes of Transmission, Precautions, and Economic Impact on Dentistry-A Review Article
by: Mohammed Tahir Abdalqadir
Published: (2020-05-01) -
Hospitalizations for bronchiolitis among infants before and after the SARS-CoV-2 pandemic: an area-based study of the Emilia-Romagna Region, Italy
by: Elisa Ballardini, et al.
Published: (2025-02-01) -
COVID-19 Lockdowns Improve Air Quality in the South-East Asian Regions, as Seen by the Remote Sensing Satellites
by: Abirlal Metya, et al.
Published: (2024-12-01)